Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 4,515 | 3,142 | 0 | 0 | 0 |
| Cost of Goods | 2,400 | 1,496 | N/A | N/A | N/A |
| Gross Profit | 2,115 | 1,646 | N/A | N/A | N/A |
| Operating Expenses | 2,139 | 1,949 | 1 | 18 | -1 |
| Operating Income | 288 | 193 | -1 | -18 | 1 |
| Interest Expense | 123 | 95 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 7 | -7 |
| Pre-tax Income | 165 | 99 | -1 | -11 | -7 |
| Income Tax | -92 | 40 | N/A | N/A | N/A |
| Net Income Continuous | 257 | 59 | -1 | -11 | -7 |
| Minority Interests | N/A | -1 | 0 | 0 | 1 |
| Net Income | $257 | $59 | $-4 | $-11 | $-8 |
| EPS Basic Total Ops | 0.12 | 0.02 | 0.00 | -0.08 | -0.02 |
| EPS Basic Continuous Ops | 0.08 | 0.02 | 0.00 | -0.04 | -0.02 |
| EPS Diluted Total Ops | 0.12 | 0.02 | 0.00 | -0.08 | -0.02 |
| EPS Diluted Continuous Ops | 0.08 | 0.02 | 0.00 | -0.04 | -0.02 |
| EBITDA(a) | $464 | $355 | $-1 | $-18 | $1 |